SYRE Similar Chart Price Prediction
The price of SYRE is predicted to go up -8.86%, based on the high correlation periods with ETO. The similarity of these two price pattern on the periods is 96.6%.
SYRE
ETO
Down: -8.86%Similarity: 96.6%
SYRE Revenue Forecast
SYRE EPS Forecast
SYRE FAQs
What is SYRE eps forecast for next quarter？
SYRE Analyst's Forecast
Colleen Kusy
Baird
Buy
2024-11-13
Price Target
$50 → $65
Upside
+97.09%
Baird raised the firm's price target on Spyre Therapeutics to $65 from $50 and keeps an Outperform rating on the shares. The firm said they posted better-than-expected initial data from SPY001 and thinks the data incrementally de-risks its lead asset and broad pipeline, which could offer best-in-class dosing and potentially improved efficacy in IBD.
